PLG0206 has the potential to be the first approved therapy specifically indicated for the treatment of periprosthetic joint infection Pittsburgh, PA [ July 19, 2022]: Peptilogics, a biotech company engineering peptide therapeutics

A Pittsburgh biotech company's developing nonantibotic treatment for the sometimes deadly impact of joint replacement surgery will have a presence this week at a global infectious disease conference that will be held in Portugal this weekend. By 

Ellen Sherberg, Bizwomen Contributor Feb 4, 2022, 10:57am EST As Omnicron continues to take a toll on the country, we’re reminded how many women are on the front lines of health care. Some in the hospital setting, some as public health leaders